Characteristics of patients with serotype 5 pneumococcal pneumonia
H. Lawrence (Nottingham, United Kingdom), V. Baskaran (Nottingham, United Kingdom), H. Pick (Nottingham, United Kingdom), P. Daniel (Derby, United Kingdom), C. Rodrigo (Nottingham, United Kingdom), D. Ashton (Nottingham, United Kingdom), R. Edwards-Pritchard (Nottingham, United Kingdom), C. Sheppard (London, United Kingdom), D. Litt (London, United Kingdom), N. Fry (London, United Kingdom), S. Rose (London, United Kingdom), T. Mckeever (Nottingham, United Kingdom), W. Lim (Nottingham, United Kingdom)
Source: Virtual Congress 2020 – Clinical challenges in pneumonia
Session: Clinical challenges in pneumonia
Session type: E-poster session
Number: 2029
Disease area: Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Lawrence (Nottingham, United Kingdom), V. Baskaran (Nottingham, United Kingdom), H. Pick (Nottingham, United Kingdom), P. Daniel (Derby, United Kingdom), C. Rodrigo (Nottingham, United Kingdom), D. Ashton (Nottingham, United Kingdom), R. Edwards-Pritchard (Nottingham, United Kingdom), C. Sheppard (London, United Kingdom), D. Litt (London, United Kingdom), N. Fry (London, United Kingdom), S. Rose (London, United Kingdom), T. Mckeever (Nottingham, United Kingdom), W. Lim (Nottingham, United Kingdom). Characteristics of patients with serotype 5 pneumococcal pneumonia. 2029
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Impact of pneumococcal vaccination in children in the distribution of serotypes in bacteriemic pneumococcal pneumonia in adults Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis Year: 2017
Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumonia Source: Eur Respir J 2010; 36: 1073-1079 Year: 2010
Clinical features of adults with seven-valent- conjugated-vaccine- serotype pneumococcal pneumonia Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013
A longitudinal analysis of pneumococcal vaccine serotypes in pneumonia patients in Germany Source: Eur Respir J, 59 (2) 2102432; 10.1183/13993003.02432-2021 Year: 2022
Risk factors for respiratory failure in pneumococcal pneumonia: the importance of pneumococcal serotypes Source: Eur Respir J 2014; 43: 545-553 Year: 2013
The remaining challenges of pneumococcal disease in adults Source: Eur Respir Rev 2012; 21: 57-65 Year: 2012
Changes in pathogens and pneumococcal serotypes causing community-acquired pneumonia in The Netherlands Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis Year: 2017
A study of the prevalence of streptococcus pneumoniae serotypes in patients hospitalised for community-acquired pneumonia Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016
Prognostic score systems and community-acquired bacteraemic pneumococcal pneumonia Source: Eur Respir J 2006 Oct 01;28(4):816-823 Year: 2006
Evolution of antimicrobial resistance trends in the last five years in patients with bacteremic Pneumococcal community-acquired pneumonia (CAP-SP) Source: Eur Respir J 2005; 26: Suppl. 49, 639s Year: 2005
Clinical effectiveness of pneumococcal vaccination against nonbacteremic pneumonia in people over 50 years Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention Year: 2008
Predictors of treatment failure in patients with bacteremic pneumococcal community-acquired pneumonia Source: Annual Congress 2013 –Pneumonia and sepsis Year: 2013
Evolution of serotype coverages of 23- and 7-valent pneumococcal vacciness for S. pneumonia isolates from Spanish middle age and older adults with pneumonia, 2002-2007 Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention Year: 2008
Absence of leukocytosis in bacteremic pneumococcal pneumonia Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia Year: 2009
Complicated pneumococcal pneumonia in adults Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia Year: 2009
An outbreak of streptococcus pneumonia serotype 1 pneumonia in a UK primary school Source: Annual Congress 2007 - Paediatric respiratory epidemiology: rare diseases, infectious diseases and asthma Year: 2007
Protective effect of pneumococcal vaccine against death by pneumonia in elderly subjects Source: Eur Respir J 2005; 26: 1086-1091 Year: 2005
Sepsis severity predicts outcome in community-acquired pneumococcal pneumonia Source: Eur Respir J 2007; 30: 517-524 Year: 2007
Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia Source: Eur Respir J 2015; 45: 1632-1641 Year: 2015